Cargando…

Carbon fibres as potential bone implants with controlled doxorubicin release

This work presents the structural characterisation of carbon fibres obtained from the carbonization of flax tow at 400°C (CFs400°C) and 1000°C (CFs1000°C) and the thermodynamic and kinetic studies of adsorption of Doxorubicin (Dox) on the fibres. The characteristic of carbon fibres and their drug ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Chudoba, Dorota, Łudzik, Katarzyna, Jażdżewska, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850544/
https://www.ncbi.nlm.nih.gov/pubmed/35173195
http://dx.doi.org/10.1038/s41598-022-06044-7
_version_ 1784652620410912768
author Chudoba, Dorota
Łudzik, Katarzyna
Jażdżewska, Monika
author_facet Chudoba, Dorota
Łudzik, Katarzyna
Jażdżewska, Monika
author_sort Chudoba, Dorota
collection PubMed
description This work presents the structural characterisation of carbon fibres obtained from the carbonization of flax tow at 400°C (CFs400°C) and 1000°C (CFs1000°C) and the thermodynamic and kinetic studies of adsorption of Doxorubicin (Dox) on the fibres. The characteristic of carbon fibres and their drug adsorption and removal mechanism were investigated and compared with that of natural flax tow. All fibres were fully characterized by scanning electron microscopy (SEM), Fourier transforms infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), specific surface area analysis and Boehm titration. The results demonstrated the highest adsorption properties of CFs400°C at 323 K (q(max) = 275 mg g(−1)). The kinetic data followed the pseudo-second-order kinetic model more closely, whereas the Dubinin–Radushkevich model suitably described isotherms for all fibres. Calculated parameters revealed that the adsorption process of Dox ions is spontaneous and mainly followed by physisorption and a pore-filling mechanism. The removal efficiency for carbon fibres is low due to the effect of pore-blocking and hydrophobic hydration. However, presented fibres can be treated with a base for further chemical surface modification, increasing the adsorption capacity and controlling the release tendency.
format Online
Article
Text
id pubmed-8850544
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88505442022-02-17 Carbon fibres as potential bone implants with controlled doxorubicin release Chudoba, Dorota Łudzik, Katarzyna Jażdżewska, Monika Sci Rep Article This work presents the structural characterisation of carbon fibres obtained from the carbonization of flax tow at 400°C (CFs400°C) and 1000°C (CFs1000°C) and the thermodynamic and kinetic studies of adsorption of Doxorubicin (Dox) on the fibres. The characteristic of carbon fibres and their drug adsorption and removal mechanism were investigated and compared with that of natural flax tow. All fibres were fully characterized by scanning electron microscopy (SEM), Fourier transforms infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), specific surface area analysis and Boehm titration. The results demonstrated the highest adsorption properties of CFs400°C at 323 K (q(max) = 275 mg g(−1)). The kinetic data followed the pseudo-second-order kinetic model more closely, whereas the Dubinin–Radushkevich model suitably described isotherms for all fibres. Calculated parameters revealed that the adsorption process of Dox ions is spontaneous and mainly followed by physisorption and a pore-filling mechanism. The removal efficiency for carbon fibres is low due to the effect of pore-blocking and hydrophobic hydration. However, presented fibres can be treated with a base for further chemical surface modification, increasing the adsorption capacity and controlling the release tendency. Nature Publishing Group UK 2022-02-16 /pmc/articles/PMC8850544/ /pubmed/35173195 http://dx.doi.org/10.1038/s41598-022-06044-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Chudoba, Dorota
Łudzik, Katarzyna
Jażdżewska, Monika
Carbon fibres as potential bone implants with controlled doxorubicin release
title Carbon fibres as potential bone implants with controlled doxorubicin release
title_full Carbon fibres as potential bone implants with controlled doxorubicin release
title_fullStr Carbon fibres as potential bone implants with controlled doxorubicin release
title_full_unstemmed Carbon fibres as potential bone implants with controlled doxorubicin release
title_short Carbon fibres as potential bone implants with controlled doxorubicin release
title_sort carbon fibres as potential bone implants with controlled doxorubicin release
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850544/
https://www.ncbi.nlm.nih.gov/pubmed/35173195
http://dx.doi.org/10.1038/s41598-022-06044-7
work_keys_str_mv AT chudobadorota carbonfibresaspotentialboneimplantswithcontrolleddoxorubicinrelease
AT łudzikkatarzyna carbonfibresaspotentialboneimplantswithcontrolleddoxorubicinrelease
AT jazdzewskamonika carbonfibresaspotentialboneimplantswithcontrolleddoxorubicinrelease